New Anthranilic Acid Hydrazones as Fenamate Isosteres: Synthesis, Characterization, Molecular Docking, Dynamics & in Silico ADME, in Vitro Anti‐Inflammatory and Anticancer Activity Studies
Chemistry & Biodiversity · 2023-08 · 20 (8)
DOI: 10.1002/cbdv.202300773 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 17.07.2023. Verfasst von Halil Şenol und 3 weiteren Autor:innen. Beteiligte Einrichtung: Bezmialem Vakif University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Fatih, 34093, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Fenamates, Antineoplastic Agents. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Bezmialem Vakif University, Bezmialem Vakıf Üniversitesi.
Abstract (Originalsprache)
In this study, twenty new anthranilic acid hydrazones 6 – 9 ( a – e ) were synthesized and their structures were characterized by Fourier‐transform Infrared (FT‐IR), Nuclear Magnetic Resonance ( 1 H‐NMR – 13 C‐NMR), and High‐resolution Mass Spectroscopy (HR‐MS). The inhibitory effects of the compounds against COX‐II were evaluated. IC 50 values of the compounds were found in the range of >200–0.32 μM and compounds 6e , 8d , 8e , 9b , 9c , and 9e were determined to be the most effective inhibitors. Cytotoxic effects of the most potent compounds were investigated against human hepatoblastoma (Hep‐G2) and human healthy embryonic kidney (Hek‐293) cell lines. Doxorubicin (IC 50 : 8.68±0.16 μM for Hep‐G2, 55.29±0.56 μM for Hek‐293) was used as standard. 8e is the most active compound, with low IC 50 against Hep‐G2 (4.80±0.04 μM), high against Hek‐293 (159.30±3.12), and high selectivity (33.15). Finally, molecular docking and dynamics studies were performed to understand ligand‐protein interactions between the most potent compounds and COX II, Epidermal Growth Factor Receptor (EGFR), and Transforming Growth Factor beta II (TGF‐βII). The docking scores were calculated in the range of −10.609–−6.705 kcal/mol for COX‐II, −8.652–−7.743 kcal/mol for EGFR, and −10.708–−8.596 kcal/mol for TGF‐βII.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bezmialem Vakif University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Fatih, 34093, Istanbul, Türkiye.
- Bezmialem Vakif University, Faculty of Pharmacy, Department of Biochemistry, Fatih, 34093, Istanbul, Türkiye.
- Bezmialem Vakif University, Institute of Health Sciences, Department of Biotechnology, 34093, İstanbul, Türkiye.
- Kafkas University, Kars Vocational School, Department of Material and Material Processing Technologies, 36100, Kars, Türkiye.
Förderung
- Bezmialem Vakif University
- Bezmialem Vakıf Üniversitesi
Zitieren
APA
Şenol, H., Çağman, Z., Gençoğlu Katmerlikaya, T., & Sinan Tokalı, F. (2023). New Anthranilic Acid Hydrazones as Fenamate Isosteres: Synthesis, Characterization, Molecular Docking, Dynamics & in Silico ADME, in Vitro Anti‐Inflammatory and Anticancer Activity Studies. Chemistry & Biodiversity, 20(8). https://doi.org/10.1002/cbdv.202300773
Vancouver
Şenol H, Çağman Z, Gençoğlu Katmerlikaya T, Sinan Tokalı F. New Anthranilic Acid Hydrazones as Fenamate Isosteres: Synthesis, Characterization, Molecular Docking, Dynamics & in Silico ADME, in Vitro Anti‐Inflammatory and Anticancer Activity Studies. Chemistry & Biodiversity. 2023;20(8). doi:10.1002/cbdv.202300773
BibTeX
@article{enol2023,
author = {Şenol, Halil and Çağman, Zeynep and Gençoğlu Katmerlikaya, Tuğba and Sinan Tokalı, Feyzi},
title = {New Anthranilic Acid Hydrazones as Fenamate Isosteres: Synthesis, Characterization, Molecular Docking, Dynamics & in Silico ADME, in Vitro Anti‐Inflammatory and Anticancer Activity Studies},
journal = {Chemistry & Biodiversity},
year = {2023},
volume = {20},
number = {8},
doi = {10.1002/cbdv.202300773}
}
EUVIMED